Form 4: Vaxart Director W. Mark Watson Acquires 20,000 Shares of Common Stock
SEC Form 4 Filing
Vaxart director W. Mark Watson purchased 20,000 shares of common stock at a price of $0.6789 per share on June 18, 2024.
Summary
- On June 18, 2024, W. Mark Watson, a director of Vaxart, Inc., acquired 20,000 shares of common stock.
- The purchase price was $0.6789 per share.
- Following the transaction, Watson directly owns 78,125 shares of Vaxart common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. A purchase by a director is generally viewed more favorably than a sale.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/18/2024 | Date of transaction: W. Mark Watson acquired 20,000 shares of Vaxart common stock. |
| 06/20/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.